LYB-001

N/A

Report date: 2022/12/29 20:00:28

Base Information

Drug NameLYB-001
Drug Alias NameSARS-CoV-2 Vaccine(Patronus Biotech)基于VLP技术路线的新冠疫苗（烟台派诺生物）LYB-001
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesYantai Patronus Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Patronus Biotech Co LtdYantai Patronus Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A